环丙沙星对弯曲杆菌属及其他肠道病原菌的体外活性比较
Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.
作者信息
Goodman L J, Fliegelman R M, Trenholme G M, Kaplan R L
出版信息
Antimicrob Agents Chemother. 1984 Apr;25(4):504-6. doi: 10.1128/AAC.25.4.504.
Abstract
A comparison was made of the in vitro activity of ciprofloxacin (Bay o 9867) with nine other antibiotics against isolates of Campylobacter jejuni, Salmonella spp., Shigella spp., Yersinia enterocolitica, Clostridium difficile, Vibrio spp., and Escherichia coli. Minimum inhibitory concentrations of ciprofloxacin were the lowest of any compound tested for all organisms except C. difficile.
摘要
对环丙沙星（拜耳o 9867）与其他九种抗生素针对空肠弯曲菌、沙门氏菌属、志贺氏菌属、小肠结肠炎耶尔森菌、艰难梭菌、弧菌属和大肠杆菌分离株的体外活性进行了比较。除艰难梭菌外，环丙沙星对所有受试微生物的最低抑菌浓度在所有测试化合物中是最低的。
相似文献
1
Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.环丙沙星对弯曲杆菌属及其他肠道病原菌的体外活性比较
Antimicrob Agents Chemother. 1984 Apr;25(4):504-6. doi: 10.1128/AAC.25.4.504.
2
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.十二种4-喹诺酮类抗菌药物对肠道病原体的体外活性比较
Drugs Exp Clin Res. 1985;11(4):253-7.
3
Antimicrobial Susceptibility of Campylobacter isolates in the Capital of North Macedonia.北马其顿首都弯曲杆菌分离株的抗菌药敏性
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019 Oct 1;40(2):73-80. doi: 10.2478/prilozi-2019-0017.
4
In vitro activity of lomefloxacin and other antimicrobials against bacterial enteritis pathogens.
Diagn Microbiol Infect Dis. 1992 May-Jun;15(4):339-43. doi: 10.1016/0732-8893(92)90020-t.
5
[Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].[10种新型4-喹诺酮类药物对肠道致病菌的体外活性比较]
Pathol Biol (Paris). 1987 Jun;35(5 Pt 2):800-4.
6
Comparison of the in vitro activity of ciprofloxacin (Bay o 9867) and norfloxacin against gastrointestinal tract pathogens.
Eur J Clin Microbiol. 1984 Aug;3(4):367. doi: 10.1007/BF01977497.
7
[Antibacterial activity of fosfomycin against the causative bacteria isolated from bacterial enteritis].
Jpn J Antibiot. 2000 Jul;53(7):522-31.
8
Potential clinical use of azithromycin against gastroenteritis-causing pathogens other than Campylobacter.
New Microbiol. 2020 Oct;43(4):198-200. Epub 2020 Sep 4.
9
[In vitro antimicrobial activity of DR-3355, a new quinolone antibacterial agent, against clinical isolates of enteritis-causing bacteria].
Kansenshogaku Zasshi. 1992 Jan;66(1):51-8. doi: 10.11150/kansenshogakuzasshi1970.66.51.
10
[In vitro antibacterial activity of fleroxacin (FLRX) against clinical isolates from bacterial enteritis].氟罗沙星（FLRX）对细菌性肠炎临床分离株的体外抗菌活性
Kansenshogaku Zasshi. 1994 Nov;68(11):1409-16. doi: 10.11150/kansenshogakuzasshi1970.68.1409.
引用本文的文献
1
Prevalence of Genetic Determinants and Phenotypic Resistance to Ciprofloxacin in from Lithuania.立陶宛环丙沙星基因决定因素及表型耐药性的流行情况
Front Microbiol. 2018 Feb 14;9:203. doi: 10.3389/fmicb.2018.00203. eCollection 2018.
2
The new quinolones in the treatment of diarrhoea and typhoid fever.新型喹诺酮类药物在腹泻和伤寒治疗中的应用
Drugs. 1995;49 Suppl 2:132-5. doi: 10.2165/00003495-199500492-00021.
3
Isolation of Campylobacter jejuni strains resistant to nalidixic acid and fluoroquinolones from children with diarrhea in Athens, Greece.
Eur J Clin Microbiol Infect Dis. 1993 Jul;12(7):566-8. doi: 10.1007/BF01970969.
4
Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis.脂质体包裹的环丙沙星治疗小鼠沙门氏菌病
Antimicrob Agents Chemother. 1993 Nov;37(11):2293-7. doi: 10.1128/AAC.37.11.2293.
5
Quinolones in the treatment of acute bacterial diarrhoeal diseases.喹诺酮类药物在急性细菌性腹泻疾病治疗中的应用
Drugs. 1993;45 Suppl 3:114-8. doi: 10.2165/00003495-199300453-00019.
6
In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents.致病性弧菌属对诺氟沙星及其他六种抗菌剂的体外敏感性
Antimicrob Agents Chemother. 1985 Sep;28(3):442-5. doi: 10.1128/AAC.28.3.442.
7
Comparative in vitro activities of selected antimicrobial agents against Edwardsiella tarda.所选抗菌剂对迟缓爱德华氏菌的体外比较活性
Antimicrob Agents Chemother. 1985 Jun;27(6):966-7. doi: 10.1128/AAC.27.6.966.
8
Comparative in vitro activities of selected antimicrobial agents against Aeromonas species and Plesiomonas shigelloides.所选抗菌剂对气单胞菌属菌种和类志贺邻单胞菌的体外比较活性
Antimicrob Agents Chemother. 1985 Apr;27(4):643-5. doi: 10.1128/AAC.27.4.643.
9
Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species.十二种抗菌剂对弯曲杆菌属细菌的体外活性比较
Antimicrob Agents Chemother. 1985 Mar;27(3):429-30. doi: 10.1128/AAC.27.3.429.
10
Pharmacokinetics of ciprofloxacin tablets in renal failure; influence of haemodialysis.
Eur J Clin Pharmacol. 1987;31(5):589-93. doi: 10.1007/BF00606636.
本文引用的文献
1
Hippurate hydrolysis by Campylobacter fetus.胎儿弯曲菌对马尿酸盐的水解作用。
J Clin Microbiol. 1980 Apr;11(4):435-7. doi: 10.1128/jcm.11.4.435-437.1980.
2
Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens.十种抗菌剂对细菌性肠道病原体的体外活性比较
Antimicrob Agents Chemother. 1983 Oct;24(4):509-13. doi: 10.1128/AAC.24.4.509.
3
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.新型喹啉衍生物Bay 09867与其他抗菌药物的体外活性比较。
Antimicrob Agents Chemother. 1983 Apr;23(4):559-64. doi: 10.1128/AAC.23.4.559.
4
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.诺氟沙星（MK - 0366，AM - 715）及其他药物对胃肠道病原体的体外抗菌活性。
Antimicrob Agents Chemother. 1983 Jan;23(1):86-90. doi: 10.1128/AAC.23.1.86.
Zotero 插件